Biotech7 months ago
Novo Nordisk Buys Catalent for 10.66 Billion to Produce More Wegovy
Wegovy stands as Novo Nordisk's big bet. This medicine was what placed the Danish multinational company as the most valuable company in Europe last September, surpassing...